Literature DB >> 18551017

High-sugar diets increase cardiac dysfunction and mortality in hypertension compared to low-carbohydrate or high-starch diets.

Naveen Sharma1, Isidore C Okere, Brian R Barrows, Biao Lei, Monika K Duda, Celvie L Yuan, Stephen F Previs, Victor G Sharov, Agnes M Azimzadeh, Paul Ernsberger, Brian D Hoit, Hani Sabbah, William C Stanley.   

Abstract

OBJECTIVE: Sugar consumption affects insulin release and, in hypertension, may stimulate cardiac signaling mechanisms that accelerate left ventricular hypertrophy and the development of heart failure. We investigated the effects of high-fructose or sucrose diets on ventricular function and mortality in hypertensive Dahl salt-sensitive rats.
METHODS: Rats were fed chows that were either high starch (70% starch, 10% fat by energy), high fat (20% carbohydrates, 60% fat), high fructose (61% fructose, 9% starch, 10% fat), or high sucrose (61% sucrose, 9% starch, 10% fat). Hypertension was induced by adding 6% salt to the chow (n = 8-11/group).
RESULTS: After 8 weeks of treatment, systolic blood pressure and left ventricular mass were similarly increased in all rats that were fed high-salt diets. Hypertension caused a switch in mRNA myosin heavy chain isoform from alpha to beta, and this effect was greater in the high-salt sucrose and fructose groups than in starch and fat groups. The cardiac mRNA for atrial natriuretic factor was also increased in all high-salt groups compared to respective controls, with the increase being significantly greater in the hypertensive sucrose fed group. Mortality was greater in the sucrose group (44%) compared to all the other hypertensive groups (12-18%), as was cardiomyocyte apoptosis. Left ventricular ejection fraction was lower in the high-salt sucrose group, which was due to an increase in end-systolic volume, and not increased end-diastolic volume.
CONCLUSION: Diets high in sugar accelerated cardiac systolic dysfunction and mortality in hypertension compared to either a low-carbohydrate/high-fat or high-starch diet.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551017      PMCID: PMC3103886          DOI: 10.1097/HJH.0b013e3283007dda

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  40 in total

Review 1.  Measuring in vivo metabolism using heavy water.

Authors:  Danielle Dufner; Stephen F Previs
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2003-09       Impact factor: 4.294

2.  Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart.

Authors:  Rakhee S Gupte; Venkataramana Vijay; Brian Marks; Robert J Levine; Hani N Sabbah; Michael S Wolin; Fabio A Recchia; Sachin A Gupte
Journal:  J Card Fail       Date:  2007-08       Impact factor: 5.712

3.  High fructose diet increases mortality in hypertensive rats compared to a complex carbohydrate or high fat diet.

Authors:  Naveen Sharma; Isidore C Okere; Monika K Duda; Janean Johnson; Celvie L Yuan; Margaret P Chandler; Paul Ernsberger; Brian D Hoit; William C Stanley
Journal:  Am J Hypertens       Date:  2007-04       Impact factor: 2.689

4.  Rapamycin attenuates load-induced cardiac hypertrophy in mice.

Authors:  Tetsuo Shioi; Julie R McMullen; Oleg Tarnavski; Kimber Converso; Megan C Sherwood; Warren J Manning; Seigo Izumo
Journal:  Circulation       Date:  2003-03-17       Impact factor: 29.690

5.  Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure.

Authors:  H N Sabbah; V G Sharov; R C Gupta; A Todor; V Singh; S Goldstein
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

6.  Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.

Authors:  H N Sabbah; W C Stanley; V G Sharov; T Mishima; M Tanimura; C R Benedict; S Hegde; S Goldstein
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

7.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

Authors:  Darrell D Belke; Sandrine Betuing; Martin J Tuttle; Christophe Graveleau; Martin E Young; Mark Pham; Dongfang Zhang; Robert C Cooksey; Donald A McClain; Sheldon E Litwin; Heinrich Taegtmeyer; David Severson; C Ronald Kahn; E Dale Abel
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

8.  Akt signaling mediates postnatal heart growth in response to insulin and nutritional status.

Authors:  Ichiro Shiojima; Mikkael Yefremashvili; Zhengyu Luo; Yasuko Kureishi; Akihiro Takahashi; Jingzang Tao; Anthony Rosenzweig; C Ronald Kahn; E Dale Abel; Kenneth Walsh
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

Review 9.  Sugars, hypertriglyceridemia, and cardiovascular disease.

Authors:  Susan K Fried; Salome P Rao
Journal:  Am J Clin Nutr       Date:  2003-10       Impact factor: 7.045

Review 10.  Sugars, insulin sensitivity, and the postprandial state.

Authors:  Mark Daly
Journal:  Am J Clin Nutr       Date:  2003-10       Impact factor: 7.045

View more
  23 in total

1.  High-sugar intake does not exacerbate metabolic abnormalities or cardiac dysfunction in genetic cardiomyopathy.

Authors:  Peter A Hecker; Tatiana F Galvao; Karen M O'Shea; Bethany H Brown; Reney Henderson; Heather Riggle; Sachin A Gupte; William C Stanley
Journal:  Nutrition       Date:  2012-02-02       Impact factor: 4.008

Review 2.  Type 2 diabetes, mitochondrial biology and the heart.

Authors:  Michael N Sack
Journal:  J Mol Cell Cardiol       Date:  2009-02-13       Impact factor: 5.000

3.  Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.

Authors:  Senthil Selvaraj; Daniel P Kelly; Kenneth B Margulies
Journal:  Circulation       Date:  2020-06-01       Impact factor: 29.690

4.  Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction.

Authors:  Monika K Duda; Karen M O'Shea; Biao Lei; Brian R Barrows; Agnes M Azimzadeh; Tracy E McElfresh; Brian D Hoit; Willem J Kop; William C Stanley
Journal:  J Card Fail       Date:  2008-05       Impact factor: 5.712

5.  Early developmental exposure to high fructose intake in rats with NaCl stimulation causes cardiac damage.

Authors:  I C Araujo; R P Andrade; F Santos; E S Soares; R Yokota; C Mostarda; P Fiorino; K De Angelis; M C Irigoyen; M Morris; V Farah
Journal:  Eur J Nutr       Date:  2015-01-07       Impact factor: 5.614

Review 6.  Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.

Authors:  William C Stanley; Erinne R Dabkowski; Rogerio F Ribeiro; Kelly A O'Connell
Journal:  Circ Res       Date:  2012-03-02       Impact factor: 17.367

7.  Effects of glucose-6-phosphate dehydrogenase deficiency on the metabolic and cardiac responses to obesogenic or high-fructose diets.

Authors:  Peter A Hecker; Rudo F Mapanga; Charlene P Kimar; Rogerio F Ribeiro; Bethany H Brown; Kelly A O'Connell; James W Cox; Kadambari C Shekar; Girma Asemu; M Faadiel Essop; William C Stanley
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-24       Impact factor: 4.310

8.  High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects.

Authors:  Tatiana F Galvao; Bethany H Brown; Peter A Hecker; Kelly A O'Connell; Karen M O'Shea; Hani N Sabbah; Sharad Rastogi; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Cardiovasc Res       Date:  2011-09-29       Impact factor: 10.787

9.  A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload.

Authors:  David J Chess; Ramzi J Khairallah; Karen M O'Shea; Wenhong Xu; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

10.  Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure.

Authors:  Julie H Rennison; Tracy A McElfresh; Xiaoqin Chen; Vijay R Anand; Brian D Hoit; Charles L Hoppel; Margaret P Chandler
Journal:  J Mol Cell Cardiol       Date:  2009-03-03       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.